Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated traditional Chinese and Western medicine after PCI for acute coronary syndrome
ChiCTR-TRC-07000021Phase 4Completed
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Start
- Dec 2007
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Xinyue Capsule and Xiongshao capsule in acute coronary syndrome (ACS) (2 arms), sponsored by Xiyuan Hospital of China Academy of Chinese Medical Sciences. Primary endpoints: Mortality and Cardiovascular event rate. Started Dec 2007; status: completed.
02
Drugs
Xinyue CapsuleXiongshao capsule
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-TRC-07000021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-07000021.